Contract analysis

I. Executive Summary This memorandum provides a comprehensive status report on the above-captioned patent infringement action brought by Optiwave Semiconductor Corp. ("OWS" or "Plaintiff") against Lumos Photonics, Inc. ("Lumos" or "Defendant") in the United States District Court for the Northern District of California, San Jose Division, before the Honorable Edward J. Torvelis. The reporting period covers all activit

II. Litigation Activity Summary A. Complaint Filing and Service (June 2022) The Complaint in this action was filed on June 3, 2022 in the United States District Court for the Northern District of California, San Jose Division, and the matter was opened at Calderwood & Harkness LLP under matter number 1014-00003. The case was assigned to the Honorable Edward J. Torvelis and designated Case No. 5:22-cv-03417-EJD. The C

1. U.S. Patent No. 10,234,567 (the "'567 Patent") — entitled "Integrated Waveguide Coupler with Tapered Mode Converter for Low-Loss Fiber-to-Chip Optical Coupling," issued to OWS on March 19, 2019. This patent covers the design of an adiabatically coupled waveguide structure employing a tapered mode converter to achieve efficient optical coupling between single-mode fiber and on-chip waveguides.

2. U.S. Patent No. 10,891,234 (the "'234 Patent") — entitled "Germanium-on-Silicon Photodetector with Graded Buffer Layer for High-Bandwidth Optical Reception," issued to OWS on January 12, 2021. This patent covers a photodetector architecture utilizing a graded buffer layer with a continuously varying germanium concentration to reduce threading dislocation density and improve responsivity.

3. U.S. Patent No. 11,045,678 (the "'678 Patent") — entitled "Multi-Channel Optical Transceiver with Integrated Wavelength-Division Multiplexing on a Single Silicon Die," issued to OWS on June 29, 2021. This patent covers a transceiver architecture in which a wavelength-division multiplexing (WDM) element is monolithically formed on a single silicon die, enabling compact multi-channel operation.

4. U.S. Patent No. 11,312,890 (the "'890 Patent") — entitled "Driver Circuit Architecture for High-Speed Silicon Photonic Mach-Zehnder Modulator with Integrated Pre-Emphasis Equalization," issued to OWS on April 26, 2022. This patent covers a driver circuit topology in which a pre-emphasis equalization stage is electrically co-integrated with a Mach-Zehnder modulator on a common substrate. The Complaint identifies th

III. Claim Construction Phase — Current Status The case is currently in the claim construction phase, which represents the most significant pre-trial milestone. The following subsections provide a detailed summary of all claim construction activity to date and the current status of preparation for the Markman hearing. A. Exchange of Claim Construction Contentions Pursuant to Patent Local Rule 4-1 of the Northern Dist

1. Dr. Kevin Fong (Chief Technology Officer, OWS; named inventor on the '567, '234, and '890 Patents) Dr. Fong's deposition was noticed by Lumos and taken on October 18, 2022, at the offices of Calderwood & Harkness LLP. Lumos's examination focused on Dr. Fong's understanding of the claimed inventions, the meaning of key claim terms (including "adiabatically coupled," "continuously varying germanium concentration," a

2. Hideo Tanaka (former Senior Engineer, OWS; named inventor on the '567 Patent; co-inventor of prior art U.S. Patent No. 9,456,012) Mr. Tanaka's deposition was noticed by Lumos and is scheduled for October 29, 2022, at the offices of Brannick Howell & Stein LLP. Mr. Tanaka's testimony is expected to cover his contributions to the '567 invention, his understanding of the term "adiabatically coupled," and — critically

3. Dr. Amara Osei (Principal Engineer, Photonics Design Group, OWS; named inventor on the '234 and '678 Patents) Dr. Osei's deposition was noticed by Lumos and taken on October 21, 2022, at the offices of Calderwood & Harkness LLP. Lumos's examination focused on Dr. Osei's understanding of the terms "continuously varying germanium concentration" (specifically, whether a step-graded buffer would be understood by a POS

IV. Fact discovery — Upcoming Fact discovery has not yet formally commenced beyond the exchange of initial disclosures on August 22, 2022 and the limited claim construction discovery described in Section III.C above. The Case Management Order establishes a fact discovery period that will extend through mid-2023 (specific deadline to be confirmed following the Markman hearing). The following fact discovery activities

V. Expert Engagement — Damages In addition to the claim construction technical expert (Dr. Whitfield) discussed in Section III.D above, Calderwood & Harkness has engaged a damages expert on behalf of OWS. Dr. Lawrence Kessler of Apex Claim Analytics LLC (150 North Michigan Avenue, Suite 2400, Chicago, Illinois 60601) has been retained as OWS's damages expert for this matter. The retention agreement was executed in Oc

VI. Pre-Litigation Patent Portfolio Valuation Prior to the filing of this action, OWS engaged Clearpath IP Valuation Services, Inc. (100 Summer Street, Suite 1500, Boston, Massachusetts 02110) to conduct a comprehensive valuation of OWS's patent portfolio. The valuation was led by Jennifer Armitage, CFA, CLP, a principal at Clearpath with extensive experience in semiconductor IP valuation. The key findings of the Cle

VII. Key Risk Factors and Assessment A. Claim Construction Risk The Markman hearing, scheduled for January 30, 2023, represents the most critical near-term event in this case. The outcome of claim construction will largely determine the trajectory of the litigation, including whether OWS's infringement theories are viable as to each of the accused products and whether Lumos's invalidity defenses gain traction. The pr

VIII. Financial Summary — Fees, Costs, and Budget A. Fee and Cost Summary (Through October 28, 2022) The following table summarizes the attorney fees billed by timekeeper for the reporting period of June 3, 2022 through October 28, 2022. All rates reflect the 10% volume discount negotiated under the OWS / Calderwood & Harkness engagement agreement: The following table summarizes costs and disbursements incurred to da

1. Claim Construction Briefing and Markman Hearing Preparation (December 2022 – January 2023): This phase is expected to be one of the most resource-intensive periods of the litigation, involving the drafting of the Opening and Reply Claim Construction Briefs, preparation of Dr. Whitfield's declaration, finalization of hearing demonstratives, and moot court preparation. Estimated incremental cost: $275,000 – $350,000

2. Commencement of Fact discovery (November 2022 – mid-2023): The service, review, and response to document requests, preparation and defense of depositions, and ESI document review will constitute the bulk of the litigation spend. Estimated incremental cost for the fact discovery phase: $800,000 – $1,200,000.

3. Expert discovery (to be scheduled following fact discovery): Expert reports, depositions, and supplemental analyses. Estimated incremental cost: $400,000 – $600,000. A revised budget forecast will be provided in the January 2023 matter status report, following the Markman hearing, when the impact of the Court's claim constructions on the scope and complexity of the remaining case can be assessed.

IX. Next Steps and Key Upcoming Dates The following table summarizes the key upcoming dates and action items: The Markman hearing on January 30, 2023 is the most significant upcoming milestone and will be the primary focus of the Calderwood & Harkness team through the end of January. The outcome of the hearing will substant